Jan Jan  De Witte net worth and biography

Jan De Witte Biography and Net Worth

JAN DE WITTE joined Integra in December 2021 as president and chief executive officer.

Mr. De Witte has an extensive track record in the global healthcare industry spanning more than two decades. Prior to joining Integra, Mr. De Witte served as chief executive officer of Barco N.V., a global technology leader based in Belgium focused on networked visualization solutions, including for the healthcare market. At Barco, he created shareholder value through digital innovation and new product development, commercial acceleration, international market growth and operational excellence. Prior to Barco, Mr. De Witte spent 17 years in senior-level leadership roles at GE, including as president and CEO of GE Global Healthcare IT. Prior to GE, De Witte spent five years in strategic consulting at McKinsey and three years in operations at Procter & Gamble.

Additionally, Mr. De Witte also serves on the board of directors of ResMed, a global leader in digital health technologies and cloud-connected medical devices that transform care for people with sleep apnea, COPD and other chronic diseases. He has also been an active community leader serving as the chair of Hangar K innovation hub in Belgium and a board member of Ghent University.

Mr. De Witte holds a master’s of science degree in electromechanical engineering with greatest distinction from the KU Leuven in Belgium and a master’s degree in business administration from Harvard University. He has lived and worked in seven countries, with much of his career spent in the U.S., and is fluent in three languages.

What is Jan Jan De Witte's net worth?

The estimated net worth of Jan Jan De Witte is at least $146,561.40 as of November 12th, 2024. Mr. De Witte owns 6,723 shares of Integra LifeSciences stock worth more than $146,561 as of December 21st. This net worth evaluation does not reflect any other assets that Mr. De Witte may own. Additionally, Mr. De Witte receives an annual salary of $888,670.00 as CEO at Integra LifeSciences. Learn More about Jan Jan De Witte's net worth.

How old is Jan Jan De Witte?

Mr. De Witte is currently 60 years old. There are 7 older executives and no younger executives at Integra LifeSciences. Learn More on Jan Jan De Witte's age.

What is Jan Jan De Witte's salary?

As the CEO of Integra LifeSciences Holdings Co., Mr. De Witte earns $888,670.00 per year. Learn More on Jan Jan De Witte's salary.

How do I contact Jan Jan De Witte?

The corporate mailing address for Mr. De Witte and other Integra LifeSciences executives is 311 ENTERPRISE DRIVE, PLAINSBORO NJ, 08536. Integra LifeSciences can also be reached via phone at (609) 275-0500 and via email at [email protected]. Learn More on Jan Jan De Witte's contact information.

Has Jan Jan De Witte been buying or selling shares of Integra LifeSciences?

Jan Jan De Witte has not been actively trading shares of Integra LifeSciences during the past quarter. Most recently, on Thursday, June 1st, Witte Jan De bought 7,792 shares of Integra LifeSciences stock. The stock was acquired at an average cost of $38.50 per share, with a total value of $299,992.00. Following the completion of the transaction, the chief executive officer now directly owns 12,798 shares of the company's stock, valued at $492,723. Learn More on Jan Jan De Witte's trading history.

Who are Integra LifeSciences' active insiders?

Integra LifeSciences' insider roster includes Richard Caruso (Major Shareholder), Glenn Coleman (COO), Jan De Witte (CEO), Stuart Essig (Director), Lisa Evoli (EVP), Michael McBreen (EVP), Jeffrey Mosebrook (SVP), Raymond Murphy (Director), and Eric Schwartz (EVP). Learn More on Integra LifeSciences' active insiders.

Are insiders buying or selling shares of Integra LifeSciences?

In the last year, Integra LifeSciences insiders bought shares 1 times. They purchased a total of 52,641 shares worth more than $1,499,742.09. In the last year, insiders at the life sciences company sold shares 1 times. They sold a total of 1,700 shares worth more than $41,072.00. The most recent insider tranaction occured on December, 2nd when EVP Michael J Mcbreen sold 1,700 shares worth more than $41,072.00. Insiders at Integra LifeSciences own 3.1% of the company. Learn More about insider trades at Integra LifeSciences.

Information on this page was last updated on 12/2/2024.

Jan Jan De Witte Insider Trading History at Integra LifeSciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/1/2023Buy7,792$38.50$299,992.0012,798View SEC Filing Icon  
See Full Table

Jan Jan De Witte Buying and Selling Activity at Integra LifeSciences

This chart shows Witte Jan De's buying and selling at Integra LifeSciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Integra LifeSciences Company Overview

Integra LifeSciences logo
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
Read More

Today's Range

Now: $21.80
Low: $21.31
High: $22.29

50 Day Range

MA: $22.54
Low: $18.76
High: $26.70

2 Week Range

Now: $21.80
Low: $16.81
High: $45.42

Volume

1,517,085 shs

Average Volume

1,059,520 shs

Market Capitalization

$1.68 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.15